Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients

NCT06665737 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

126

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non-Hodgkin's Lymphoma (NHL)
Granulocyte Colony Stimulating Factor
Febrile Neutropenia (FN)
Myelosuppression Adult

Interventions

DRUG: Early receiving G-CSF group
DRUG: Late receiving G-CSF group

Sponsor

Department of Medical Services Ministry of Public Health of Thailand

Collaborators

[object Object]
[object Object]